Skip to main content
Beginner 4 min read

Tamoxifen: What It Is and What to Expect

Tamoxifen is a hormone therapy for breast cancer approved for breast cancer, DCIS and risk reduction

NCI source:National Cancer Institute — Tamoxifen Citrate

Review status: AI-assisted, editorial review complete. Not reviewed by a clinician. How we check pages

The short answer

Tamoxifen is a hormone therapy for breast cancer. NCI calls it a SERM: it blocks estrogen's effects in some tissues and mimics them in others. It is approved for breast cancer in women and men, for DCIS, and to lower risk in some high-risk women. Like all cancer medicines it can cause side effects; this page explains the common ones and the warning signs to report. It is educational only and not a substitute for your care team's advice.

  • Tamoxifen is a hormone therapy (a SERM) used for breast cancer.

  • It is approved for breast cancer in women and men, for DCIS, and to lower risk in some high-risk women.

  • Common side effects include hot flashes, vaginal discharge and fluid retention; tell your care team about anything new or worsening.

Choose how you want to read this

The whole article, with every detail and caution.

This page is for people prescribed tamoxifen and those who support them. It covers how it works, what it treats, its boxed warning, and the side effects to know about.

A pill that blocks estrogen in breast tissue

Many breast cancers have estrogen receptors on their cells. Estrogen slots into those receptors and tells the cell to grow.

Tamoxifen sits in that slot instead. It fits, but it does not deliver the growth message, so the receptor is occupied and the signal never arrives.

NCI says tamoxifen is a selective estrogen receptor modulator (SERM). It blocks estrogen's effects in some tissues and mimics them in others.

Tamoxifen is the generic name. This page's DailyMed source covers the tablets.

What it is approved for

NCI and the FDA label list these uses.

  1. Metastatic breast cancer, in women and in men.
  2. After surgery (adjuvant treatment) for node-positive and node-negative breast cancer.
  3. DCIS (ductal carcinoma in situ, cancer cells still inside the milk ducts).
  4. Lowering risk in women at high risk who do not have breast cancer. The label defines high risk as age 35 or older with a 5-year predicted risk of 1.67% or more on the Gail model.

Who the boxed warning is actually about

Tamoxifen carries an FDA boxed warning, and it is aimed at a specific group. The warning is often quoted as though it applied to everyone.

The box is headed "For Women with Ductal Carcinoma in Situ (DCIS) and Women at High Risk for Breast Cancer." It covers serious events seen in the risk-reduction setting: uterine cancers, stroke and a clot in the lung. Some were fatal.

The warning is about those settings. Ask your team how it applies to you, and why you are taking tamoxifen.

Vaginal bleeding is the symptom to report

The FDA label notes an increased rate of uterine cancers with tamoxifen, including endometrial cancer and uterine sarcoma. It says abnormal vaginal bleeding should be promptly evaluated.

So report any abnormal vaginal bleeding to your team right away. Do not wait for a routine appointment.

Clots, and a medicine that does not mix

The label lists a clot in the lung (pulmonary embolism) and other clotting events as serious risks. Sudden breathlessness, chest pain, or coughing blood means calling 911 or going straight to an emergency department. Swelling, pain or warmth in one calf means calling your care team right away.

For the DCIS and risk-reduction uses, the label says tamoxifen must not be used in women who need coumarin-type blood thinners such as warfarin. Tell your team about every medicine you take.

Side effects, and not stopping on your own

The label lists hot flashes, vaginal discharge and fluid retention among the common reactions. Tell your care team if side effects are affecting your life. Talk with them before you stop, even if you feel well.

Tamoxifen can harm a developing baby. The label says premenopausal women must use effective nonhormonal contraception while taking it and for about 2 months after stopping.

Sources

An older woman and female clinician look over medication bottles, smiling

Common questions

What is Tamoxifen?

Tamoxifen is a hormone therapy for breast cancer. NCI calls it a SERM. It is approved for breast cancer in women and men, for DCIS, and to lower risk in some high-risk women.

How is Tamoxifen given?

Your care team sets the dose and how long you take it. Take it as prescribed and talk with your team before stopping, even if you feel well.

What are the common side effects of Tamoxifen?

The FDA label lists hot flashes, vaginal discharge and fluid retention among the common reactions. Not everyone gets them, and many can be managed. Tell your care team about anything new or worsening.

Does Tamoxifen cure cancer?

That depends on the person, the cancer type, and its stage. For some people a medicine like this can control cancer for a long time or be part of a curative plan; for others the goal is to slow the cancer or ease symptoms. Your care team can explain the goal in your situation.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Talk to a person

Talk with a trained specialist or navigator

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Prepared by Cancer Explained's AI-assisted editorial system

Written from National Cancer Institute material and compared with the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-10-02 what this meansLast updated: 2026-10-02Next planned review: 2027-01-14

Review details and limits

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

More on this topic

Words to know

Tap any term to see what it means.

Browse the full glossary →

Knowledge check

0 of 2 answered

  1. Q1.What kind of medicine is Soltamox?
  2. Q2.Which of these is Soltamox used to help treat?

This self-assessment checks understanding of educational content only. It is not medical advice.

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.